波士顿咨询（BCG）：2025生物制药趋势研究报告：复杂环境下的创新先行（英文版）（12页）.pdf

1、BIOPHARMA TRENDS 2025 Focusing on Innovation amid ComplexityJanuary 2025 By Margot Bleys,Bilal Khan,John Wu,and Priya ChandranBoston Consulting Group Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportuniti

2、es.BCG was the pioneer in business strategy when it was founded in 1963.Today,we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholdersempowering organizations to grow,build sustainable competitive advantage,and drive positive societal impact.Our divers

3、e,global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change.BCG delivers solutions through leading-edge management consulting,technology and design,and corporate and digital ventures.We work in a uniquely collaborative model a

4、cross the firm and throughout all levels of the client organization,fueled by the goal of helping our clients thrive and enabling them to make the world a better place.BIOPHARMA TRENDS 2025:FOCUSING ON INNOVATION AMID COMPLEXITY 3Countervailing winds of change are a constant in the biopharma industr

5、y,and they are picking up speed.Novel treatments based on innovative science and new modalities are emerging faster than ever.Intensifying competition,declining R&D productivity,payer pressures,and a steep patent cliff are testing the economic viability of biopharmas business model.More than ever,bi

6、opharma is a high-stakes business,fraught with risks.But it also remains capable of delivering life-changing benefits to patients worldwide.There are a couple of reasons why any management team can look to an uncertain future with confidence.First,this is a unique moment.An unprecedented level of kn